BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29752431)

  • 21. DNA damage-binding complex recruits HDAC1 to repress Bcl-2 transcription in human ovarian cancer cells.
    Zhao R; Han C; Eisenhauer E; Kroger J; Zhao W; Yu J; Selvendiran K; Liu X; Wani AA; Wang QE
    Mol Cancer Res; 2014 Mar; 12(3):370-80. PubMed ID: 24249678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EHMT1 promotes tumor progression and maintains stemness by regulating ALDH1A1 expression in alveolar rhabdomyosarcoma.
    Nachiyappan A; Soon JLJ; Lim HJ; Lee VK; Taneja R
    J Pathol; 2022 Mar; 256(3):349-362. PubMed ID: 34897678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cisplatin induces stemness in ovarian cancer.
    Wiechert A; Saygin C; Thiagarajan PS; Rao VS; Hale JS; Gupta N; Hitomi M; Nagaraj AB; DiFeo A; Lathia JD; Reizes O
    Oncotarget; 2016 May; 7(21):30511-22. PubMed ID: 27105520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression-ALDH1A1, CD133, CD44-For Survival and Long-Term Follow-Up of Ovarian Cancer Patients.
    Izycka N; Rucinski M; Andrzejewska M; Szubert S; Nowak-Markwitz E; Sterzynska K
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2
    Liu L; Cai S; Han C; Banerjee A; Wu D; Cui T; Xie G; Zhang J; Zhang X; McLaughlin E; Yin M; Backes FJ; Chakravarti A; Zheng Y; Wang QE
    Mol Cancer Ther; 2020 Jan; 19(1):199-210. PubMed ID: 31534014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutual Expression of ALDH1A1, LOX, and Collagens in Ovarian Cancer Cell Lines as Combined CSCs- and ECM-Related Models of Drug Resistance Development.
    Sterzyńska K; Klejewski A; Wojtowicz K; Świerczewska M; Nowacka M; Kaźmierczak D; Andrzejewska M; Rusek D; Brązert M; Brązert J; Nowicki M; Januchowski R
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30583585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ALDH1A1 maintains the cancer stem-like cells properties of esophageal squamous cell carcinoma by activating the AKT signal pathway and interacting with β-catenin.
    Wang W; He S; Zhang R; Peng J; Guo D; Zhang J; Xiang B; Li L
    Biomed Pharmacother; 2020 May; 125():109940. PubMed ID: 32044720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
    Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
    Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.
    Silva IA; Bai S; McLean K; Yang K; Griffith K; Thomas D; Ginestier C; Johnston C; Kueck A; Reynolds RK; Wicha MS; Buckanovich RJ
    Cancer Res; 2011 Jun; 71(11):3991-4001. PubMed ID: 21498635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptomic Analysis of Breast Cancer Stem Cells and Development of a pALDH1A1:mNeptune Reporter System for Live Tracking.
    Bidan N; Bailleul-Dubois J; Duval J; Winter M; Denoulet M; Hannebicque K; El-Sayed IY; Ginestier C; Forissier V; Charafe-Jauffret E; Macario M; Matsunaga YT; Meignan S; Anquez F; Julien S; Bonnefond A; Derhourhi M; Le Bourhis X; Lagadec C
    Proteomics; 2019 Nov; 19(21-22):e1800454. PubMed ID: 31430054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription.
    Gorodetska I; Offermann A; Püschel J; Lukiyanchuk V; Gaete D; Kurzyukova A; Freytag V; Haider MT; Fjeldbo CS; Di Gaetano S; Schwarz FM; Patil S; Borkowetz A; Erb HHH; Baniahmad A; Mircetic J; Lyng H; Löck S; Linge A; Lange T; Knopf F; Wielockx B; Krause M; Perner S; Dubrovska A
    Theranostics; 2024; 14(2):714-737. PubMed ID: 38169509
    [No Abstract]   [Full Text] [Related]  

  • 32. ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression.
    Liu C; Qiang J; Deng Q; Xia J; Deng L; Zhou L; Wang D; He X; Liu Y; Zhao B; Lv J; Yu Z; Lei QY; Shao ZM; Zhang XY; Zhang L; Liu S
    Cancer Res; 2021 Dec; 81(23):5919-5934. PubMed ID: 34580061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells.
    Yao W; Wang L; Huang H; Li X; Wang P; Mi K; Cheng J; Liu H; Gu C; Huang L; Huang J
    BMC Cancer; 2020 Apr; 20(1):315. PubMed ID: 32293355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma.
    Qian X; Wagner S; Ma C; Coordes A; Gekeler J; Klussmann JP; Hummel M; Kaufmann AM; Albers AE
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1151-8. PubMed ID: 24770634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low P16
    Fu HC; Chuang IC; Yang YC; Chuang PC; Lin H; Ou YC; Chang Chien CC; Huang HS; Kang HY
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30150594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD10
    Ffrench B; Gasch C; Hokamp K; Spillane C; Blackshields G; Mahgoub TM; Bates M; Kehoe L; Mooney A; Doyle R; Doyle B; O'Donnell D; Gleeson N; Hennessy BT; Stordal B; O'Riain C; Lambkin H; O'Toole S; O'Leary JJ; Gallagher MF
    Cell Death Dis; 2017 Oct; 8(10):e3128. PubMed ID: 29048400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative expression analysis of putative cancer stem cell markers CD44 and ALDH1A1 in various skin cancer subtypes.
    Erfani E; Roudi R; Rakhshan A; Sabet MN; Shariftabrizi A; Madjd Z
    Int J Biol Markers; 2016 Feb; 31(1):e53-61. PubMed ID: 26391478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells.
    Zhao D; Mo Y; Li MT; Zou SW; Cheng ZL; Sun YP; Xiong Y; Guan KL; Lei QY
    J Clin Invest; 2014 Dec; 124(12):5453-65. PubMed ID: 25384215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-6 mediates platinum-induced enrichment of ovarian cancer stem cells.
    Wang Y; Zong X; Mitra S; Mitra AK; Matei D; Nephew KP
    JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer.
    Su Y; Qiu Q; Zhang X; Jiang Z; Leng Q; Liu Z; Stass SA; Jiang F
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):327-37. PubMed ID: 20142235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.